Form 4 for AXGN Axogen, Inc.
Accepted 2022-12-29 00:00:00 ET · period of report 2022-12-27 · accession 0000805928-22-000135 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-29 | 2022-12-27 | AXGN | Zaderej Karen L. | CEO, Dir | M - OptEx | $0.00 | +4,400 | 1.01M | +0.4% | $0 |
| D | 2022-12-29 | 2022-12-27 | AXGN | Zaderej Karen L. | CEO, Dir | M - OptEx | $0.00 | +4,400 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-27 | M | A | 4,400 | $0.00 | 1,012,695 | D | — | — | (F1) This reflects the number of restricted stock units that vested on December 27, 2022. |
| 2 | Derivative | Restricted Stock Units | 2022-12-27 | M | A | 4,400 | $0.00 | 0 | D | — · — to — | 4,400 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F3) All shares of AxoGen Inc. common stock underlying the restricted stock units vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. |